Pharma and Biotech
Competitors: | Okyo Pharma Limited , Hemogenyx Pharmaceuticals |
Executive Director: | Daniel Gooding |
Independent Non-Executive Director: | Madeleine Kennedy |
Non-Executive Chairman: | Julian Gilbert |
Non-Executive Dir: |
Address: | 6th Floor, 60 Gracechurch Street, London, United Kingdom, EC3V 0HR |
Phone: | +44 (0)1223 627222 |
Website: | https://nuformix.com/ |
Sector: | Pharma and Biotech(LSE) |
ISIN: | GB00BYW79Y38 |
Currency | UK Pounds |
Share Price | 0.048p |
Change Today | 0.003p |
% Change | -5.00 % |
52 Week High | 0.40p |
52 Week Low | 0.046p |
Volume | 13,310,496 |
Shares Issued | 1,419.31m |
Market Cap | £0.67m |
Beta | 0.07 |
RiskGrade | 322 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
11:05 | 223,350 @ 0.049p |
11:00 | 1,076,902 @ 0.047p |
09:51 | 2,010,244 @ 0.049p |
09:20 | 10,000,000 @ 0.046p |
You are here: research